Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MET
stocks logo

MET

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
18.57B
-0.61%
2.333
+2.33%
18.56B
+5.36%
2.394
+22.75%
19.05B
-3.48%
2.433
+16.41%
Estimates Revision
The market is revising Downward the revenue expectations for MetLife, Inc. (MET) for FY2025, with the revenue forecasts being adjusted by -0.57% over the past three months. During the same period, the stock price has changed by -5.25%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.57%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-2.87%
In Past 3 Month
Stock Price
Go Down
down Image
-5.25%
In Past 3 Month
11 Analyst Rating
up Image0
Wall Street analysts forecast MET stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MET is 93.45 USD with a low forecast of 86.00 USD and a high forecast of 100.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Buy
1 Hold
0 Sell
Strong Buy
up Image0
Current: 77.850
sliders
Low
86.00
Averages
93.45
High
100.00
up Image0
Current: 77.850
sliders
Low
86.00
Averages
93.45
High
100.00
Morgan Stanley
Overweight
maintain
$94 -> $99
2025-05-19
Reason
Morgan Stanley
Price Target
$94 -> $99
2025-05-19
maintain
Overweight
Reason
Morgan Stanley raised the firm's price target on MetLife to $99 from $94 and keeps an Overweight rating on the shares. The firm is updating its price targets on stocks under its coverage in the Life Insurance sector, the analyst tells investors. Morgan Stanley notes core results held up well and a rebound is expected to occur in 2H25. Overall, valuation is attractive for the sector, the firm says.
Barclays
Alex Scott
Buy
Maintains
$95 → $88
2025-04-11
Reason
Barclays
Alex Scott
Price Target
$95 → $88
2025-04-11
Maintains
Buy
Reason
Morgan Stanley
Nigel Dally
Buy
Maintains
$109 → $94
2025-04-10
Reason
Morgan Stanley
Nigel Dally
Price Target
$109 → $94
2025-04-10
Maintains
Buy
Reason
Morgan Stanley lowered the firm's price target on MetLife to $94 from $109 and keeps an Overweight rating on the shares. On average across the firm's life insurance coverage, Q1 EPS estimates declined 3% from prior estimates and its 2025 EPS estimates declined 4% from prior estimates, though results vary across companies, notes the analyst in a preview for the group. For underwriting-oriented companies that should not be as sensitive to equity market fluctuations, the firm's estimates generally did not change as much, but it still moved underwriter estimates down as they likely face an incrementally more challenging operating environment, the analyst noted.
Wells Fargo
Elyse Greenspan
Buy
Maintains
$97 → $91
2025-04-10
Reason
Wells Fargo
Elyse Greenspan
Price Target
$97 → $91
2025-04-10
Maintains
Buy
Reason
Wells Fargo lowered the firm's price target on MetLife to $91 from $97 and keeps an Overweight rating on the shares. The firm notes that the quarter lost a little luster with the tariff backdrop and Wells thinks a bigger focus will be on any views of tariffs/ensuring macro backdrop.
Keefe, Bruyette & Woods
Ryan Krueger
Buy
Maintains
$98 → $95
2025-04-09
Reason
Keefe, Bruyette & Woods
Ryan Krueger
Price Target
$98 → $95
2025-04-09
Maintains
Buy
Reason
Keefe Bruyette analyst Ryan Krueger lowered the firm's price target on MetLife to $95 from $98 and keeps an Outperform rating on the shares.
JP Morgan
Jimmy Bhullar
Buy
Maintains
$88 → $86
2025-04-02
Reason
JP Morgan
Jimmy Bhullar
Price Target
$88 → $86
2025-04-02
Maintains
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for MetLife Inc (MET.N) is 8.46, compared to its 5-year average forward P/E of 8.26. For a more detailed relative valuation and DCF analysis to assess MetLife Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
8.26
Current PE
8.46
Overvalued PE
9.45
Undervalued PE
7.07

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
3.78
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
9.70
Undervalued EV/EBITDA
-2.14

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
0.71
Current PS
0.72
Overvalued PS
0.80
Undervalued PS
0.62

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 119940.49% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

MET News & Events

Events Timeline

(ET)
2025-05-19
13:03:06
MetLife appoints Jane Slusark as CCO
select
2025-04-30 (ET)
2025-04-30
16:16:50
MetLife reports Q1 adjusted EPS $1.96, consensus $2.00
select
2025-04-30
16:14:38
MetLife board approves new $3B share repurchase authorization
select
Sign Up For More Events
Sign Up For More Events

News

Preview
2.0
06-17Newsfilter
Most Personal Injury Structured Settlement Annuity Recipients Report That Receiving Annuity Payments Makes Them Feel Financially Secure, According to New MetLife Study

  • Structured Settlement Benefits: A recent MetLife study reveals that 96% of structured settlement annuity recipients prefer monthly payments over lump sums, with 94% feeling financially secure and 79% reporting an improved standard of living since receiving their annuities.

  • Lump Sum Spending Concerns: The study indicates that nearly half of lump sum recipients regret significant purchases made within the first year, leading to financial uncertainty, as 51% are cutting back on spending due to fears of running out of money.

Preview
3.0
06-16NASDAQ.COM
Add Up The Parts: IAK Could Be Worth $148

  • ETF Analysis: The iShares U.S. Insurance ETF (IAK) has an implied analyst target price of $147.87, indicating an 11.68% upside from its current trading price of $132.40. Notable underlying holdings with significant upside include Kemper Corp, MetLife Inc, and Genworth Financial.

  • Investor Considerations: Analysts' target prices may reflect optimism or could be outdated, prompting the need for further research by investors to assess the validity of these targets in light of recent developments in the companies and industry.

Preview
5.0
06-11Newsfilter
New PPO Dental Plans More Competitive Against HMOs

  • Expansion of PPO Dental Plans: DentalInsurance.com has expanded its offerings of PPO dental plans with significantly higher maximum benefits, ranging from $2,500 to $10,000, making them more appealing to consumers seeking quality dental care without high out-of-pocket costs.

  • Consumer Awareness: The company emphasizes the importance for consumers to read insurance conditions carefully to understand any exclusions or limitations on specific services when selecting high maximum benefit plans.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is MetLife Inc (MET) stock price today?

The current price of MET is 77.85 USD — it has decreased -0.7 % in the last trading day.

arrow icon

What is MetLife Inc (MET)'s business?

MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.

arrow icon

What is the price predicton of MET Stock?

Wall Street analysts forecast MET stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MET is 93.45 USD with a low forecast of 86.00 USD and a high forecast of 100.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is MetLife Inc (MET)'s revenue for the last quarter?

MetLife Inc revenue for the last quarter amounts to 18.56B USD, increased 15.79 % YoY.

arrow icon

What is MetLife Inc (MET)'s earnings per share (EPS) for the last quarter?

MetLife Inc. EPS for the last quarter amounts to 1.28 USD, increased 16.36 % YoY.

arrow icon

What changes have occurred in the market's expectations for MetLife Inc (MET)'s fundamentals?

The market is revising Downward the revenue expectations for MetLife, Inc. (MET) for FY2025, with the revenue forecasts being adjusted by -0.57% over the past three months. During the same period, the stock price has changed by -5.25%.
arrow icon

How many employees does MetLife Inc (MET). have?

MetLife Inc (MET) has 45000 emplpoyees as of June 18 2025.

arrow icon

What is MetLife Inc (MET) market cap?

Today MET has the market capitalization of 52.26B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free